Tourmaline Bio Overview

Life ScienceCompany

Was Tourmaline Bio formerly PE-backed?

Yes. Tourmaline Bio was formerly owned by 1 private investor.

Where is Tourmaline Bio headquartered?

Tourmaline Bio is headquartered in New York, New York.

What is Tourmaline Bio’s revenue?

Tourmaline Bio disclosed revenue of 45M USD for 2023 and 20M USD for 2022.

How many employees does Tourmaline Bio have?

Tourmaline Bio has 74 employees.

What sector is Tourmaline Bio in?

Tourmaline Bio is a life science company.

When was Tourmaline Bio founded?

Tourmaline Bio was founded in 2021.

Tourmaline Bio

Tourmaline Bio, Inc.

27 West 24th Street, Suite 702,
New York, New York 10010
United States,
(646) 481-9832
www.tourmalinebio.com

Tourmaline Bio is a late-clinical stage biotechnology company that is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. Tourmaline Bio was founded in 2021 and is based in New York, New York.


M&A Summary

Buy vs Sell

Year '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - 1 - - 1
Sell (0.0/yr) # - - - - - 0
  1

Top M&A Advisors

Financial Deals
Leerink Partners
1
Legal Deals
Goodwin Procter
1

Try Mergr Free — See This and 221,260+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.